First Command Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History

First Command Advisory Services's REGN Position: Q2 2026 in Review

First Command Advisory Services held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 5 shares worth $3.12K. The position accounts for ﹤0.01% of the portfolio, ranked #933.

First Command Advisory Services first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.86K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

• First Command Advisory Services held 5 shares of Regeneron Pharmaceuticals worth $3.12K as of Q2 2026.
• First Command Advisory Services left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
• Regeneron Pharmaceuticals made up ﹤0.01% of First Command Advisory Services's portfolio in Q2 2026, its #933 holding.
• First Command Advisory Services first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
• First Command Advisory Services's Regeneron Pharmaceuticals position peaked at $3.86K in Q1 2026.
• 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on First Command Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.